Showing results (1-10 of 73) with videos related to
Sort By:
Pageof 8
Genes & Development|July 14, 2025
Cancer mortality and senescence: Is redox therapy an option?Shan Kuang, Manojit M Swamynathan, Lloyd C TrotmanAnalytical Chemistry|March 23, 2023
Internally Controlled and Dynamic Optical Measures of Functional Tumor BiologyTaemoon Chung, Libia Garcia, Manojit M Swamynathan, et al.Bioorganic & Medicinal Chemistry|March 9, 2025
Fatty acid binding protein 5 inhibitors as novel anticancer agents against metastatic castration-resistant prostate cancerHehe Wang, Chuanzhou Zhu, Manojit M Swamynathan, et al.Trends in Cell Biology|April 13, 2013
PTEN plasticity: how the taming of a lethal gene can go too farAdam Naguib, Lloyd C TrotmanThe Journal of Experimental Medicine|April 3, 2020
Competence against insufficiency: Why are men mostly safe from a rare and deadly prostate cancer?Grinu Mathew, Lloyd C TrotmanAnnual Review of Pharmacology and Toxicology|January 8, 2014
Turning off AKT: PHLPP as a drug targetAlexandra C Newton, Lloyd C TrotmanCold Spring Harbor Perspectives in Medicine|December 11, 2019
PTEN: Bridging Endocytosis and SignalingMatthew F Lee, Lloyd C TrotmanCancers|January 11, 2024
FABP5 Inhibition against PTEN-Mutant Therapy Resistant Prostate CancerManojit M Swamynathan, Grinu Mathew, Andrei Aziz, et al.Cancer Drug Resistance (Alhambra, Calif.)|September 17, 2021
Advances in preclinical evaluation of experimental antibody-drug conjugatesScott K Lyons, Dennis Plenker, Lloyd C TrotmanClinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2014
Molecular pathways: PI3K pathway phosphatases as biomarkers for cancer prognosis and therapyMuhan Chen, Dawid G Nowak, Lloyd C TrotmanPageof 8